Annette Tognela

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Peter Grimison, Antony Mersiades, Adrienne Kirby et al. · Annals of Oncology · 2020 · 143 citations · Full text

Cannabis Use, Psychoactive Drug, Oral Thc +7

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Andrew R. Davidson, A.-S. Veillard, Annette Tognela et al. · Annals of Oncology · 2015 · 33 citations

Topical Nitroglycerin, Medicine, Phase Iii +11

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

Antony Mersiades, Annette Tognela, Paul Haber et al. · BMJ Open · 2018 · 27 citations · Full text

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

Daphne Day, Lisa Grech, Mike Nguyen et al. · Vaccines · 2022 · 27 citations · Full text

Population Health Sciences, Large Cross-sectional Analysis, Covid-19 Epidemiology +25

Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial

Peter Grimison, Antony Mersiades, Adrienne Kirby et al. · Journal of Clinical Oncology · 2024 · 21 citations · Full text